ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bernard Albat
Paul-André Chaptal
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albat, B.
Right arrow Articles by Chaptal, P.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albat, B.
Right arrow Articles by Chaptal, P.-A.

Ann Thorac Surg 1995;60:1772-1777
© 1995 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Myocardial Lactate Dehydrogenase Subunit Ratio in Cardiac Allograft Recipients

Bernard Albat, MD, Emile Missov, MD, Anne-Marie Boularan, MD, Marc Ferrière, MD, Isabelle Serre, MD, Bernard Descomps, MD, Paul-André Chaptal, MD

Service de Chirurgie Thoracique et Cardio-Vasculaire, Hôpital Arnaud de Villeneuve, Centre Hospitalier Universitaire de Montpellier, Montpellier, France

Accepted for publication August 9, 1995.

Background. Allograft coronary artery disease (CAD) is a major long-term complication in heart transplanted patients. However, the metabolic basis of allograft CAD remains to be fully elucidated. We analyzed the lactate dehydrogenase heart (H) and muscle (M) isoenzyme pattern in endomyocardial biopsy specimens and the evolution of the H/M ratio to test whether changes in this ratio could be the earliest manifestation of allograft CAD.

Methods. Twenty-four heart transplant recipients were followed up for 12 months. Endomyocardial biopsy was performed at 1, 2, 3, 6, and 12 months after transplantation. Lactate dehydrogenase 1 through 5 isoenzymes were separated by electrophoresis, and the H/M ratio was calculated. Two groups of patients were identified: group 1 (n = 20), patients without allograft CAD; and group 2 (n = 4), patients with poor outcome (three deaths, 1 case of low cardiac output) and angiographic and histologic evidence of allograft CAD.

Results. Both groups had similar H/M baseline values. The H/M ratio was higher (p = 0.01) in group 1 at 6 months (3.48 ± 0.64 versus 2.17 ± 0.43) and 12 months (3.76 ± 0.92 versus 2.18 ± 0.45) when compared with group 2. The H/M ratio increased from 2.78 ± 0.89 at 1 month to 3.76 ± 0.92 at 12 months (p = 0.02) in group 1 and decreased in group 2 (2.86 ± 0.49 versus 2.18 ± 0.45; not significant).

Conclusions. Changes in H/M ratio reflect an anaerobic shift in the lactate dehydrogenase isoenzyme composition and can be taken as an early indicator of allograft CAD.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.